{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:23:15Z","timestamp":1787019795437,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atherosclerotic cardiovascular disease (CVD) is the most common cause of morbidity and mortality among hemodialysis (HD) patients. It has been attributed, among other causes, to hypertension and dyslipidemia. The aim of the present study was to investigate the effect of a year-long consumption of Pomegranate juice (PJ), on two traditional cardiovascular (CV) risk factors: hypertension and lipid profile, as well as on cardiovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>101 HD patients were randomized to receive 100\u00a0cc of PJ (0.7\u00a0mM polyphenols) or matching placebo juice, three times a week for one year. The primary endpoints were traditional CV risk factors; blood pressure and lipid profile. Systolic, diastolic and pulse pressure, plasma levels of triglycerides (TG), high density lipoprotein (HDL), low density lipoprotein (LDL) and total cholesterol were monitored quarterly during the study year. Secondary endpoint was incidence of cardiovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PJ consumption yielded a significant time response improvement in systolic blood pressure, pulse pressure, triglycerides and HDL level; an improvement that was not observed in the placebo intake group. These beneficial outcomes were more pronounced among patients with hypertension, high level of triglycerides and low levels of HDL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Regular PJ consumption by HD patients reduced systolic blood pressure and improved lipid profile. These favorable changes may reduce the accelerated atherosclerosis and high incidence of CVD among HD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov registry, Identifier number:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00727519?term=juice+AND+hemodialysis&amp;rank=1\" ext-link-type=\"uri\">NCT00727519<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1475-2891-13-18","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T07:02:38Z","timestamp":1393916558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?"],"prefix":"10.1186","volume":"13","author":[{"given":"Lilach","family":"Shema-Didi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batya","family":"Kristal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifra","family":"Sela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Geron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"Ore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,4]]},"reference":[{"key":"759_CR1","doi-asserted-by":"publisher","first-page":"c47","DOI":"10.1159\/000086221","volume":"101","author":"K Kundhal","year":"2005","unstructured":"Kundhal K, Lok C: Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract. 2005, 101: c47-c52. 10.1159\/000086221.","journal-title":"Nephron Clin Pract"},{"key":"759_CR2","first-page":"S1","volume":"51","author":"AJ Collins","year":"2008","unstructured":"Collins AJ, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Zhang R, Arko C, Chen SC, et al: Excerpts from the United State renal data system 2007 annual data report. Am J Kidney Dis. 2008, 51: S1-320.","journal-title":"Am J Kidney Dis"},{"key":"759_CR3","first-page":"565","volume":"21","author":"N Maheshwari","year":"2010","unstructured":"Maheshwari N, Ansari M, Darshana M, Lal K, Ahmed K: Pattern of lipid profile in patients on maintenance hemodialysis. Saudi J Kidney Dis Transplant. 2010, 21: 565-570.","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"759_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0140-6736(09)60212-9","volume":"373","author":"H Herspink","year":"2009","unstructured":"Herspink H, Ninomiya T, Zoungas S, de- Zeeuw D, Grobbee D, Jardine M, Gallagher M, Roberts M, Cass A, Neal B, Perkovic V: Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009, 373: 1009-1015. 10.1016\/S0140-6736(09)60212-9.","journal-title":"Lancet"},{"key":"759_CR5","doi-asserted-by":"publisher","first-page":"S315","DOI":"10.1097\/01.ASN.0000081698.10331.83","volume":"14","author":"S Prichard","year":"2003","unstructured":"Prichard S: Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol. 2003, 14: S315-S320. 10.1097\/01.ASN.0000081698.10331.83.","journal-title":"J Am Soc Nephrol"},{"key":"759_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0272-6386(00)70255-1","volume":"35","author":"C Deighan","year":"2000","unstructured":"Deighan C, Caslake M, McConnell M, Boulton-Jones J, Packard C: Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low density lipoprotein formation. Am J Kidney Dis. 2000, 35: 852-862. 10.1016\/S0272-6386(00)70255-1.","journal-title":"Am J Kidney Dis"},{"key":"759_CR7","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1681\/ASN.2007020256","volume":"18","author":"V Perkovic","year":"2007","unstructured":"Perkovic V, Ninomiya T, Arima H, Gallagher M, Jardine M, Cass A, Neal B, Macmahon S, Chalmers J: Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowring: data from the PROGRESS study. J Am Soc Nephrol. 2007, 18: 2766-2772. 10.1681\/ASN.2007020256.","journal-title":"J Am Soc Nephrol"},{"key":"759_CR8","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","volume":"356","author":"Bloob pressure lowering treatment trialists' collaboration","year":"2000","unstructured":"Bloob pressure lowering treatment trialists' collaboration: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000, 356: 1955-1964.","journal-title":"Lancet"},{"key":"759_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12325-009-0025-6","volume":"26","author":"G Fabbri","year":"2009","unstructured":"Fabbri G, Maggioni A: Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?. Adv Ther. 2009, 26: 469-487. 10.1007\/s12325-009-0025-6.","journal-title":"Adv Ther"},{"key":"759_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1523-1755.2002.00109.x","volume":"61","author":"S Seliger","year":"2002","unstructured":"Seliger S, Weiss N, Gillen D, Kestenbaum B, Ball A, Sherrard D, Stehman-Breen C: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int. 2002, 61: 297-304. 10.1046\/j.1523-1755.2002.00109.x.","journal-title":"Kidney Int"},{"key":"759_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0076-6879(90)86128-I","volume":"186","author":"W Bors","year":"1990","unstructured":"Bors W, Heller W, Michel C, Saran M: Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 1990, 186: 343-355.","journal-title":"Methods Enzymol"},{"key":"759_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0955-2863(95)00168-9","volume":"7","author":"N Cook","year":"1996","unstructured":"Cook N, Samman S: Flavonoids- chemistry, metabolism, cardio protective effects and dietary sources. J Nutr Biochem. 1996, 7: 66-76. 10.1016\/0955-2863(95)00168-9.","journal-title":"J Nutr Biochem"},{"key":"759_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0021-9150(01)00412-9","volume":"158","author":"M Aviram","year":"2001","unstructured":"Aviram M, Dornfeld L: Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001, 158: 195-198. 10.1016\/S0021-9150(01)00412-9.","journal-title":"Atherosclerosis"},{"key":"759_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.clnu.2003.10.002","volume":"23","author":"M Aviram","year":"2004","unstructured":"Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, Volkova N, Presser D, Attias J, Liker H, Hayek T: Pomegranate juice consumption for 3\u00a0years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004, 23: 423-433. 10.1016\/j.clnu.2003.10.002.","journal-title":"Clin Nutr"},{"key":"759_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.amjcard.2005.05.026","volume":"96","author":"M Summer","year":"2005","unstructured":"Summer M, Elliott-Eller M, Weidner G, Daubenmier J, Chew M, Marlin R, Raisin C, Ornish D: Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. J Cardiol. 2005, 96: 810-814. 10.1016\/j.amjcard.2005.05.026.","journal-title":"J Cardiol"},{"key":"759_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/jmf.2004.7.305","volume":"7","author":"A Esmaillzadeh","year":"2004","unstructured":"Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L: Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food. 2004, 7: 305-308. 10.1089\/jmf.2004.7.305.","journal-title":"J Med Food"},{"key":"759_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.atherosclerosis.2005.09.006","volume":"187","author":"M Rosenblat","year":"2006","unstructured":"Rosenblat M, Hayek T, Aviram M: Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis. 2006, 187: 363-371. 10.1016\/j.atherosclerosis.2005.09.006.","journal-title":"Atherosclerosis"},{"key":"759_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.freeradbiomed.2012.05.013","volume":"53","author":"L Shema-Didi","year":"2012","unstructured":"Shema-Didi L, Sela S, Ore L, Shapiro G, Geron R, Moshe G, Kristal B: One year of pomegranate juice intake decreases oxidative stress, inflammation and incidence of infections in hemodialysis patients: a randomized placebo-controlled trial. Free Radic Biol Med. 2012, 53: 297-304. 10.1016\/j.freeradbiomed.2012.05.013.","journal-title":"Free Radic Biol Med"},{"key":"759_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cct.2005.08.003","volume":"27","author":"J Dumville","year":"2006","unstructured":"Dumville J, Hahn S, Miles J, Torgerson D: The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials. 2006, 27: 1-12. 10.1016\/j.cct.2005.08.003.","journal-title":"Contemp Clin Trials"},{"key":"759_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5344\/ajev.1965.16.3.144","volume":"16","author":"V Singleton","year":"1965","unstructured":"Singleton V, Rossi J: Colorimetry of total polyphenols with phosphomolybdic phosphotungstic acid reagents. Am J Emology Viticulture. 1965, 16: 144-158.","journal-title":"Am J Emology Viticulture"},{"key":"759_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF01231077","volume":"203","author":"C Ben Nasr","year":"1996","unstructured":"Ben Nasr C, Ayed N, Metche M: Quantitative determination of the polyphenols content pg pomegranate peel. Z Lebensum Unters Forsch. 1996, 203: 374-378. 10.1007\/BF01231077.","journal-title":"Z Lebensum Unters Forsch"},{"key":"759_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/00041552-199809000-00008","volume":"7","author":"C Kitiyakara","year":"1998","unstructured":"Kitiyakara C, Wilcox C: Antioxidants for hypertension. Curr Opin Nephrol Hypertens. 1998, 7: 531-538. 10.1097\/00041552-199809000-00008.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"759_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.niox.2006.03.001","volume":"15","author":"L Ignarro","year":"2006","unstructured":"Ignarro L, Byrns R, Sumi D, Nigris F, Napoli C: Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide. 2006, 15: 93-102. 10.1016\/j.niox.2006.03.001.","journal-title":"Nitric Oxide"},{"key":"759_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.niox.2005.12.004","volume":"15","author":"F Nigris","year":"2006","unstructured":"Nigris F, Williams-Ignarro S, Botti C, Sica V, Ignarro L, Napoli C: Pomegranate juice reduces oxidized low density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cell. Nitric Oxide. 2006, 15: 259-263. 10.1016\/j.niox.2005.12.004.","journal-title":"Nitric Oxide"},{"key":"759_CR25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ajcn\/84.1.252","volume":"84","author":"P Castilla","year":"2006","unstructured":"Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel J, Lucas M, Gomez-Coronado D, Ortuno J, Lasuncion M: Concentrated red grape juice exerts antioxidant, hypolipoidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr. 2006, 84: 252-262.","journal-title":"Am J Clin Nutr"},{"key":"759_CR26","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1021\/jf801756x","volume":"56","author":"W Rock","year":"2008","unstructured":"Rock W, Rosenblat M, Miller-Lotan R, Levy A, Elias M, Aviram M: Consumption pf wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 associated with high density lipoprotein and stimulates its catalytic activities. J Agric Food Chem. 2008, 56: 8704-8713. 10.1021\/jf801756x.","journal-title":"J Agric Food Chem"},{"key":"759_CR27","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI1649","volume":"101","author":"M Aviram","year":"1998","unstructured":"Aviram M, Rosenblat M, Bisgaier C, Newton R, Primo-Parmo S, La Du B: Paroxonase inhibits High-density lipoprotein oxidation and preserves its functions. J Clin Invest. 1998, 101: 1581-1590. 10.1172\/JCI1649.","journal-title":"J Clin Invest"},{"key":"759_CR28","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/ajcn\/71.5.1062","volume":"71","author":"M Aviram","year":"2000","unstructured":"Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B: Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000, 71: 1062-1076.","journal-title":"Am J Clin Nutr"},{"key":"759_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2007.01.007","volume":"195","author":"M Shiner","year":"2007","unstructured":"Shiner M, Fuhrman B, Aviram M: Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR and AP-1 pathway activation. Atherosclerosis. 2007, 195: 313-321. 10.1016\/j.atherosclerosis.2007.01.007.","journal-title":"Atherosclerosis"},{"key":"759_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1194\/jlr.M800550-JLR200","volume":"50","author":"M Rosenblat","year":"2009","unstructured":"Rosenblat M, Coleman R, Reddy S, Aviram M: Paraoxonase 2 (PON2) attenuates macrophage triglyceride accumulation via inhibition of diacyglycerol acyltransferase 1, the rate limiting enzyme in triglycerides biosynthesis. J Lipid Res. 2009, 50: 870-879.","journal-title":"J Lipid Res"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-13-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2891-13-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-13-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-13-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T18:37:33Z","timestamp":1689014253000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/1475-2891-13-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1186\/1475-2891-13-18","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,4]]},"assertion":[{"value":"22 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}